| dc.contributor.author | Goyal, R | |
| dc.contributor.author | Chalamalasetty, SB | |
| dc.contributor.author | Madan, K | |
| dc.contributor.author | Paul, SB | |
| dc.contributor.author | Arora, R | |
| dc.contributor.author | Safaya, R | |
| dc.contributor.author | Acharya, KS | |
| dc.date.accessioned | 2013-07-03T09:21:32Z | |
| dc.date.available | 2013-07-03T09:21:32Z | |
| dc.date.issued | 2007 | |
| dc.identifier.citation | KIRTDA, DRACHARYAS. 2007. Goyal R, Chalamalasetty SB, Madan K, Paul SB, Arora R, Safaya R, Acharya SK.Acral and palmo-plantar hyperpigmentation in a patient with disseminated hepatocellular carcinoma.Indian J Gastroenterol. 2007 Nov-Dec;26(6):292-3.. Indian J Gastroenterol. 2007 Nov-Dec;26(6):292-3.. | en |
| dc.identifier.uri | http://profiles.uonbi.ac.ke/sacharya/publications/goyal-r-chalamalasetty-sb-madan-k-paul-sb-arora-r-safaya-r-acharya-skacral-and | |
| dc.identifier.uri | http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/44550 | |
| dc.description.abstract | Capecitabine (5-fluorouracil prodrug) is being evaluated for the management of hepatocellular carcinoma, and is associated with a peculiar skin reaction called hand and foot syndrome (HFS). We describe one patient with HCC and drug-induced HFS | en |
| dc.language.iso | en | en |
| dc.title | Acral and palmo-plantar hyperpigmentation in a patient with disseminated hepatocellular carcinoma | en |
| dc.type | Article | en |
| local.publisher | Department of Medicine, College of Health Sciences, University of Nairobi | en |
